CASE REPORT
Published on 13 Nov 2024
Case report: The effect of induction targeted therapies in stage III driver mutants non-small cell lung cancer
doi 10.3389/fonc.2024.1286116
- 834 views
- 1 citation
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Innovative Strategies and New Insights for the Treatment of Stage III Non-Small Cell Lung Cancer
Innovative Strategies and New Insights for the Treatment of Stage III Non-Small Cell Lung Cancer
6,938
Total downloads
22k
Total views and downloads
Articles
EDITORIAL
Published on 04 Nov 2024
Editorial: Innovative strategies and new insights for the treatment of stage III non-small cell lung cancer
doi 10.3389/fonc.2024.1503613
- 444 views
SYSTEMATIC REVIEW
Published on 22 Feb 2024
Perioperative immunotherapy for stage II-III non-small cell lung cancer: a meta-analysis base on randomized controlled trials
doi 10.3389/fonc.2024.1351359
- 2,565 views
- 2 citations
ORIGINAL RESEARCH
Published on 07 Feb 2024
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy
doi 10.3389/fonc.2024.1306311
- 1,185 views
CASE REPORT
Published on 14 Sep 2023
Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review
doi 10.3389/fonc.2023.1188772
- 1,209 views
- 1 citation
SYSTEMATIC REVIEW
Published on 24 Aug 2023
Effectiveness and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
doi 10.3389/fonc.2023.1198768
- 1,532 views
- 3 citations
ORIGINAL RESEARCH
Published on 04 Jul 2023
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
doi 10.3389/fonc.2023.1208204
- 3,183 views
- 5 citations
ORIGINAL RESEARCH
Published on 27 Apr 2023
ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy
doi 10.3389/fonc.2023.1158104
- 862 views
ORIGINAL RESEARCH
Published on 27 Mar 2023
Real-world clinical practice and outcomes in treating stage III non-small cell lung cancer: KINDLE-Asia subset
doi 10.3389/fonc.2023.1117348
- 3,273 views
- 6 citations
ORIGINAL RESEARCH
Published on 13 Mar 2023
Development and validation of machine learning models to predict survival of patients with resected stage-III NSCLC
doi 10.3389/fonc.2023.1092478
- 3,251 views
- 7 citations
